Esmolol HCl

Alias: ASL-8052; Esmolol Hydrochloride; Esmolol HCL; Brevibloc; ASL-8052; Asl 8052; ASL 8052; ASL8052; ASL 8052; Brevibloc; esmolol; esmolol hydrochloride
Cat No.:V1154 Purity: ≥98%
Esmolol HCl (Brevibloc; ASL-8052; ASL 8052), the hydrochloride salt of esmolol, is a potent and cardioselective beta-blocker used to control rapid heartbeats or abnormal heart rhythms.
Esmolol HCl Chemical Structure CAS No.: 81161-17-3
Product category: Adrenergic Receptor
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
50mg
100mg
250mg
500mg
1g
2g
5g
Other Sizes

Other Forms of Esmolol HCl:

  • Esmolol-d7 hydrochloride (esmolol d7 hydrochloride (hydrochloride))
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

Esmolol HCl (Brevibloc; ASL-8052; ASL 8052), the hydrochloride salt of esmolol, is a potent and cardioselective beta-blocker used to control rapid heartbeats or abnormal heart rhythms. Esmolol is an enantiomeric pair with one asymmetric center; the (+)-enantiomer is inactive and the (-)-enantiomer is active. This is similar to other P-blockers that have an oxypropranolamine nucleus. Esmolol exhibits a swift onset and offset of action, with its primary site of action being on the conduction systems of the sinus node and atrioventricular (AV) node.

Biological Activity I Assay Protocols (From Reference)
Targets
Adrenergic receptor
ln Vitro

In vitro activity: Esmolol is an enantiomeric pair with one asymmetric center; the (+)-enantiomer is inactive and the (-)-enantiomer is active. This is similar to other P-blockers that have an oxypropranolamine nucleus. Esmolol exhibits a swift onset and offset of action, with its primary site of action being on the conduction systems of the sinus node and atrioventricular (AV) node. [1]

ln Vivo
Esmolol (20 mg/kg) infusion enhances myocardial oxygen utilization and maintains myocardial function in septic rats. In rabbits, Esmolol (5 mg/kg, intravenously) causes a dose-dependent reduction in heart rate (HR), with a maximum percent reduction of 13%. In rabbits, Esmolol (5 mg/kg, intravenously) lowers mean arterial pressure (MAP) in a dose-dependent manner, with a maximum percent reduction of 38.2%. [3] In dogs, Esmolol (300 mg/kg) suppresses AV nodal conduction, increases the effective refractory period of the right ventricle and the preload of the left ventricle, and significantly lowers heart rate, rate-pressure product, left ventricular contraction, cardiac output, and relative refractory period of the right ventricle.
Animal Protocol
5 mg/kg, i.v.
Rabbits
References

[1]. Clin Pharmacokinet . 1995 Mar;28(3):190-202.

[2]. Crit Care Med . 2005 Oct;33(10):2294-301.

[3]. Can J Anaesth . 2001 Nov;48(10):985-9.

[4]. J Cardiovasc Pharmacol . 1999 Jul;34(1):70-7.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C16H26CLNO4
Molecular Weight
331.83
Exact Mass
331.16
Elemental Analysis
C, 57.91; H, 7.90; Cl, 10.68; N, 4.22; O, 19.29
CAS #
81161-17-3
Related CAS #
Esmolol-d7 hydrochloride; 1346598-13-7
Appearance
Solid powder
SMILES
CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl
InChi Key
GEKNCWBANDDJJL-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H25NO4.ClH/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3;/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3;1H
Chemical Name
methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate;hydrochloride
Synonyms
ASL-8052; Esmolol Hydrochloride; Esmolol HCL; Brevibloc; ASL-8052; Asl 8052; ASL 8052; ASL8052; ASL 8052; Brevibloc; esmolol; esmolol hydrochloride
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~66 mg/mL (~198.9 mM)
Water: ~66 mg/mL (~198.9 mM)
Ethanol: ~66 mg/mL (~198.9 mM)
Solubility (In Vivo)
Solubility in Formulation 1: ≥ 2.75 mg/mL (8.29 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.75 mg/mL (8.29 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

View More

Solubility in Formulation 3: ≥ 2.75 mg/mL (8.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 27.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.


Solubility in Formulation 4: 100 mg/mL (301.36 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0136 mL 15.0680 mL 30.1359 mL
5 mM 0.6027 mL 3.0136 mL 6.0272 mL
10 mM 0.3014 mL 1.5068 mL 3.0136 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02120404 Active
Recruiting
Drug: Esmolol administration Septic Shock Assistance Publique -
Hôpitaux de Paris
April 2015 Phase 2
NCT05567822 Recruiting Drug: Esmolol Hydrochloride
Drug: normal saline
Pain, Acute
Esmolol
Aretaieion University Hospital October 1, 2022 Not Applicable
NCT05703048 Recruiting Drug: Esmolol Esterase
Drug: Dexmedetomidine
Patient's Satisfaction
Depth of Anesthesia
Tanta University December 30, 2022 Not Applicable
NCT05769868 Recruiting Drug: Esmolol Injection
[Brevibloc]
Cirrhosis
Diabetes Mellitus
Oncologic Disorders
Consorcio Centro de
Investigación Biomédica
en Red (CIBER)
April 18, 2023 Phase 3
NCT05694585 Not yet recruiting Drug: Esmolol
Drug: saline
Esmolol
Stress Reaction
Xiumei Song February 1, 2023 Phase 4
Biological Data
  • Esmolol HClPanels A, B and C show representative cases of IS in the animals treated with saline (a), esmolol + milrinone (E + M) (b) and E + M in the presence of Rp-cAMPS (c). Infarcted tissue is indicated with yellow color.Cardiovasc Drugs Ther. 2011 Jun; 25(3): 223–232.
  • Esmolol HCl
    Effects of reperfusion therapy with esmolol, milrinone or E + M on LV myocardial tissue PKA during ischemia/reperfusion.



    Esmolol HCl
    Panel A: Effects of reperfusion therapy with esmolol, milrinone or E + M on myocardial tissue Akt activity during ischemia/reperfusion.Cardiovasc Drugs Ther. 2011 Jun; 25(3): 223–232.
  • Esmolol HCl
    (a) Effects of reperfusion therapy with esmolol, milrinone or E + M on LV myocyte apoptosis during ischemia/reperfusion. Panels A-C show a case of total cardiocyte apoptosis in a saline-treated heart.Cardiovasc Drugs Ther. 2011 Jun; 25(3): 223–232.
Contact Us Back to top